Comparing the effect of Ranitidin and Pantoprazole on Mg level

Comparing the effect of Ranitidin and Pantoprazole on PICU patients in Imam hossein hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016120330347N1

Enrollment

Registered

2016-12-03

Start date

2016-08-17

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Magnesium deficiency.

Interventions

Intervention 1: Ranitidin, IV, 1 mg/ kg, BID, till end of the study. Intervention 2: Pantoprazol, IV, BID,1 mg / kg, till end of the study.

Treatment - Drugs

Ranitidin, IV, 1 mg/ kg, BID, till end of the study

Pantoprazol, IV, BID,1 mg / kg, till end of the study

Eligibility

Sex/Gender

All

Age

2 Months to 15 Years

Inclusion criteria

Inclusion criteria: Inclusion: age from 2 months to 15 years old children admited in PICU; consent to participate in the study. Exclusion criteria: discharging before the end of the study; any condition that need to change the dose of Ranitidin or Pantoprazole for patients e.g GI bleeding.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Magnesium level. Timepoint: Daily since 7 days. Method of measurement: Labratory kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElahe Mansouri

Isfahn University of Medical Sciences

Kosar.mansouri@gmail.com+98 31 3450 1914

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026